Purchase Order 75F40122P00191

Award Date 7/29/22
Potential Completion Date 10/28/22
Potential Value $247K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order in the amount of $202,879.31 to Cytek Biosciences, Inc. for the delivery of a Cytek Northern Lights flow cytometer and micro-sampling system. The contract has a completion date of August 10, 2022 and does not utilize a small business set-aside. Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services, and has a history of providing specialized...
Cytek Biosciences, Inc. was awarded a $496,428 firm fixed price purchase order as a total small business set-aside by the Department of Health and Human Services' Food and Drug Administration (FDA) to deliver a multiparameter spectral analyzing flow cytometer. The cytometer will support the FDA's lot release testing of future COVID-19 vaccines at its Center for Biologics Evaluation and Research in Silver Spring, Maryland, as initially solicited on August 3, 2020. As the prime contractor,...
The Department of Health and Human Services Food and Drug Administration awarded a $249,824 Firm Fixed Price purchase order to Cytek Biosciences, Inc., a manufacturer of flow cytometry products and services, to provide a Cytek Aurora Flow Cytometer system. This equipment will be used by the FDA's Center for Biologics Evaluation and Research to assess cellular markers and support the Pathogen Reduction Research Program. The contract has a completion date of September 20, 2022 and does not...
This federal contract award is for the purchase of flow cytometry products and services from Cytek Biosciences, Inc., a manufacturer of biomedical equipment. The contract has a potential value of $20,642.63 and was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The contract is a firm fixed-price purchase order with a completion date of October 12, 2024. Cytek...
This federal contract award to Cytek Biosciences, Inc., a for-profit manufacturer of specialized biomedical equipment, is a $18,548.33 firm fixed-price purchase order from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the Department of Health and Human Services. The contract is for the delivery of Cytek's advanced flow cytometry systems and associated services, including installation, training, maintenance, and technical support. These...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Cytek Biosciences, Inc., a for-profit manufacturer of advanced flow cytometry systems and laboratory instruments. The contract, valued at $39,418.00, is for the supply of a Cytek Biosciences LSR Fortessa FACS Calibur flow cytometer to support NIAID's biomedical research programs in areas such as...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Cytek Biosciences, Inc., a for-profit manufacturer of flow cytometry products and services. The $159,029.00 contract is for preventive maintenance and repair services for the agency's spectral analyzer flow cytometer systems. Cytek is a major provider of advanced flow cytometry solutions, including the Cytek Aurora and Northern Lights systems, to federal...
This is a firm fixed-price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the U.S. Department of Health and Human Services, to Cytek Biosciences, Inc., a for-profit manufacturer of flow cytometry products and services. The purpose of this $249,995.00 contract is to purchase a flow cytometry system. No set-aside was used. The original solicitation was posted on August 30, 2022, and proposals were due on September 6, 2022. Cytek...
This is a one-year firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Cytek Biosciences, Inc., a manufacturer of flow cytometry products and services. The contract has a ceiling value of $38,666.00 and covers the FACSCALIBUR, FACSCAN, and FACSCANTO flow cytometry systems. The contract does not have a set-aside designation. Cytek Biosciences is a major...
This is a $79,500.00 firm fixed price purchase order awarded by the Department of the Interior U.S. Geological Survey Office of Acquisitions and Grants to Cytek Biosciences, Inc., a manufacturer and supplier of flow cytometry products and services. The contract is for the delivery of a flow cytometer to be performed in Fremont, California. The award is not associated with a set-aside designation. Cytek Biosciences has previously provided specialized flow cytometry equipment and support...

This federal contract award to Cytek Biosciences, Inc. is for the procurement of a Multiparameter Spectral Analyzing Flow Cytometer by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA). The firm-fixed-price purchase order, valued at $247,126.75, was awarded on July 29, 2022 with a completion date of October 28, 2022. Cytek Biosciences, a for-profit manufacturer of flow cytometry products and services, will deliver and install the specialized biomedical equipment, provide training, maintenance, and support services. The contract was awarded on an unrestricted basis, without any small business set-aside. This equipment and support services will likely enhance the FDA's biomedical research capabilities related to areas such as immunology, cancer, and infectious diseases.

Generated 3/21/24, 6:16 PM